Immunization News and Research

RSS

Afghan President Hamid Karzai meets WHO chief on polio eradication

Days after Afghanistan vaccinated more than 7 million children against polio, the world's top health official and Afghan President Hamid Karzai pledged to capitalize swiftly on the country's remarkable progress towards eradicating the disease.

2 May 2007

Feasible to create a stockpile of H5N1 vaccine

Countries and vaccine manufacturers agreed on Wednesday in a meeting at WHO that it may be feasible to create a stockpile of H5N1 vaccine, and to separately develop a mechanism to ensure broader access to pandemic influenza vaccine for developing countries in the advent of a pandemic.

30 Apr 2007

Rational development of adjuvants for use in vaccination

A recent study published in Immunology Letters, the official journal of the European Federation of Immunological Societies (EFIS), describes strategies for selective priming of B cells using various adjuvants.

25 Apr 2007

WHO facilitates influenza vaccine technology transfer to developing countries

As part of a concerted effort to ensure more equitable access to a potential pandemic influenza vaccine, six developing countries are being awarded grants to establish in-country manufacturing capacity for influenza vaccine. The countries are Brazil, India, Indonesia, Mexico, Thailand and Viet Nam.

25 Apr 2007

Vaccines to prevent or slow the growth of cancerous tumors

Mayo Clinic researchers have designed a new strategy in the promising field of cancer vaccine research that's proven to be successful in boosting T cells - the immune builders akin to a super defense force against cancer cells.

19 Apr 2007

Vaccination week in the Americas

The countries of the Americas are preparing a huge promotional effort for the fifth year of Vaccination Week in the Americas, which this year aims to immunize some 55 million persons.

18 Apr 2007

FDA approves new bird flu vaccine from sanofi pasteur

The U.S. Food and Drug Administration (FDA) has announced the first approval in the United States of a vaccine for humans against the H5N1 influenza virus, commonly known as avian or bird flu.

18 Apr 2007

Escalating violence and widespread insecurity worsens shortage of health workers in Iraq

Escalating violence and widespread insecurity, combined with a worsening shortage of health workers, are putting severe pressure on the health of the Iraqi population. This pressure increases as people move within the country and into neighbouring countries in search of safer places to live.

18 Apr 2007

High levels of antibodies - low levels of cancer!

Active immunisation can stimulate the body to produce highly efficient IgE antibodies that attack tumours.

17 Apr 2007

Eradicating polio a better option than extended control of the disease

Concerns about the high perceived costs of eradicating the relatively low number of polio cases worldwide have led to recent suggestions that it is time to shift from a goal of eradication to control—abandoning eradication and allowing wild poliovirus to continue to circulate, which proponents of control believe can sustain the low number of cases.

15 Apr 2007

A wavering commitment to polio eradication is not a good option!

Concerns about the high perceived costs of eradicating the relatively low number of polio cases worldwide have led to recent suggestions that it is time to shift from a goal of eradication to control-abandoning eradication and allowing wild poliovirus to continue to circulate, which proponents of control believe can sustain the low number of cases.

12 Apr 2007

New vaccine to prevent type-1 polio three times as effective as standard vaccine

The study found that each dose of the new monovalent oral poliovirus vaccine, known as mOPV1, protected 30% of susceptible children in northern India against paralytic poliomyelitis. The standard trivalent vaccine in the same setting protected just 11% of children per dose.

12 Apr 2007

Rising vaccine costs put kids at risk

The American Academy of Pediatrics (AAP) is alarmed that the soaring costs of vaccines combined with lower reimbursements from insurance companies will lead to the under- immunization of the nation's children and unnecessary outbreaks of preventable diseases.

11 Apr 2007

Experimental flu vaccine produced using insect cells shows promise

An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.

11 Apr 2007

Study shows beneficial effects of pneumococcal conjugate vaccines in children

Routine infant immunisation with pneumococcal conjugate vaccine (PCV7) has caused a 39% fall in all-cause pneumonia hospital admission rates for American children aged under two years, according to an Article published in this week's edition of The Lancet.

8 Apr 2007

Beneficial effects of pneumococcal conjugate vaccines in children re-emphasized

Routine infant immunization with pneumococcal conjugate vaccine (PCV7) has caused a 39 percent fall in all-cause pneumonia hospital admission rates for American children under 2, according to an article published in this week's edition of The Lancet .

7 Apr 2007

Rabies vaccine approach against HIV shows promise

Rabies, a relentless, ancient scourge, may hold a key to defeating another implacable foe: HIV. Scientists at Jefferson Medical College in Philadelphia have used a drastically weakened rabies virus to ferry HIV-related proteins into animals, in essence, vaccinating them against an AIDS-like disease.

3 Apr 2007

New York progresses HPV vaccine distribution to health providers, school clinics

The New York City Department of Health and Mental Hygiene on Thursday announced that it has distributed 57,810 doses of Merck's human papillomavirus vaccine Gardasil to city health providers, including school-based health clinics, the New York Post reports.

2 Apr 2007

Six centers of excellence for influenza research and surveillance established in U.S.

The National Institute of Allergy and Infectious Diseases (NIAID) has announced it is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance.

2 Apr 2007

PCV7 vaccine reduces frequent ear infections in children

A vaccine has been shown to help reduce the number of infants and toddlers developing frequent ear infections, according to new research from Katherine A. Poehling, M.D., a pediatrician at Brenner Children's Hospital, part of Wake Forest University Baptist Medical Center.

2 Apr 2007